Karyopharm Therapeutics (KPTI) To Present At Upcoming Healthcare Conferences In February
2/6/2014 9:20:34 AM
NATICK, Mass., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, announced today that Michael Kauffman, Chief Executive Officer, is scheduled to present at the following conferences in February:
Help employers find you! Check out all the jobs and post your resume.
comments powered by